Report Detail
Global Seasonal Affective Disorder Therapeutics Market Growth (Status and Outlook) 2019-2024
- RnM3145816 |
- 19 March, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Other
Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety.
According to this study, over the next five years the Seasonal Affective Disorder Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Seasonal Affective Disorder Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Seasonal Affective Disorder Therapeutics market by product type, application, key companies and key regions.
This study considers the Seasonal Affective Disorder Therapeutics value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Light Therapy (Phototherapy)
Medication
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Pfizer
Roche
Eli Lily
GlaxoSmithKline
Teva Pharmaceuticals
Bausch Health Companies
Mylan
Sanofi
Novartis
Johnson & Johnson
Koninklijke Philips
Beurer GmbH
Lucimed (Luminette)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Seasonal Affective Disorder Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Seasonal Affective Disorder Therapeutics market by identifying its various subsegments.
Focuses on the key global Seasonal Affective Disorder Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Seasonal Affective Disorder Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Seasonal Affective Disorder Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Seasonal Affective Disorder Therapeutics Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Seasonal Affective Disorder Therapeutics Market Size 2014-2024
- 2.1.2 Seasonal Affective Disorder Therapeutics Market Size CAGR by Region
- 2.2 Seasonal Affective Disorder Therapeutics Segment by Type
- 2.2.1 Light Therapy (Phototherapy)
- 2.2.2 Medication
- 2.2.3 Others
- 2.3 Seasonal Affective Disorder Therapeutics Market Size by Type
- 2.3.1 Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type (2014-2019)
- 2.4 Seasonal Affective Disorder Therapeutics Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Others
- 2.5 Seasonal Affective Disorder Therapeutics Market Size by Application
- 2.5.1 Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Application (2014-2019)
3 Global Seasonal Affective Disorder Therapeutics by Players
- 3.1 Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Players
- 3.1.1 Global Seasonal Affective Disorder Therapeutics Market Size by Players (2017-2019)
- 3.1.2 Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Players (2017-2019)
- 3.2 Global Seasonal Affective Disorder Therapeutics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Seasonal Affective Disorder Therapeutics by Regions
- 4.1 Seasonal Affective Disorder Therapeutics Market Size by Regions
- 4.2 Americas Seasonal Affective Disorder Therapeutics Market Size Growth
- 4.3 APAC Seasonal Affective Disorder Therapeutics Market Size Growth
- 4.4 Europe Seasonal Affective Disorder Therapeutics Market Size Growth
- 4.5 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size Growth
5 Americas
- 5.1 Americas Seasonal Affective Disorder Therapeutics Market Size by Countries
- 5.2 Americas Seasonal Affective Disorder Therapeutics Market Size by Type
- 5.3 Americas Seasonal Affective Disorder Therapeutics Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Seasonal Affective Disorder Therapeutics Market Size by Countries
- 6.2 APAC Seasonal Affective Disorder Therapeutics Market Size by Type
- 6.3 APAC Seasonal Affective Disorder Therapeutics Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Seasonal Affective Disorder Therapeutics by Countries
- 7.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Type
- 7.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Seasonal Affective Disorder Therapeutics by Countries
- 8.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type
- 8.3 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Seasonal Affective Disorder Therapeutics Market Forecast
- 10.1 Global Seasonal Affective Disorder Therapeutics Market Size Forecast (2019-2024)
- 10.2 Global Seasonal Affective Disorder Therapeutics Forecast by Regions
- 10.2.1 Global Seasonal Affective Disorder Therapeutics Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Seasonal Affective Disorder Therapeutics Forecast by Type
- 10.8 Global Seasonal Affective Disorder Therapeutics Forecast by Application
11 Key Players Analysis
- 11.1 Allergan
- 11.1.1 Company Details
- 11.1.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.1.3 Allergan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Allergan News
- 11.2 Pfizer
- 11.2.1 Company Details
- 11.2.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.2.3 Pfizer Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Pfizer News
- 11.3 Roche
- 11.3.1 Company Details
- 11.3.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.3.3 Roche Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Roche News
- 11.4 Eli Lily
- 11.4.1 Company Details
- 11.4.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.4.3 Eli Lily Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Eli Lily News
- 11.5 GlaxoSmithKline
- 11.5.1 Company Details
- 11.5.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.5.3 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 GlaxoSmithKline News
- 11.6 Teva Pharmaceuticals
- 11.6.1 Company Details
- 11.6.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.6.3 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Teva Pharmaceuticals News
- 11.7 Bausch Health Companies
- 11.7.1 Company Details
- 11.7.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.7.3 Bausch Health Companies Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Bausch Health Companies News
- 11.8 Mylan
- 11.8.1 Company Details
- 11.8.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.8.3 Mylan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Mylan News
- 11.9 Sanofi
- 11.9.1 Company Details
- 11.9.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.9.3 Sanofi Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Sanofi News
- 11.10 Novartis
- 11.10.1 Company Details
- 11.10.2 Seasonal Affective Disorder Therapeutics Product Offered
- 11.10.3 Novartis Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Novartis News
- 11.11 Johnson & Johnson
- 11.12 Koninklijke Philips
- 11.13 Beurer GmbH
- 11.14 Lucimed (Luminette)
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Seasonal Affective Disorder Therapeutics . Industry analysis & Market Report on Seasonal Affective Disorder Therapeutics is a syndicated market report, published as Global Seasonal Affective Disorder Therapeutics Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Seasonal Affective Disorder Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
